ArticleInflammation research : official journal of the European Histamine Research Society ... [et al.]2025
GSDMD deficiency mitigates intestinal damage via macrophage pyroptosis control in experimental NEC.
Article in Inflammation research : official journal of the European Histamine Research Society ... [et al.], 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- ROS-Dependent GSDMD Activation Drives Intestinal Pyroptosis in Neonatal Necrotizing Enterocolitis (NEC).Cell biology international · 2026Article
- Inhibition of IP6K1 suppresses NPA formation via platelet short-chain polyphosphate polymers in necrotizing enterocolitis.Inflammation research : official journal of the European Histamine Research Society ... [et al.] · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Necrotizing enterocolitis (NEC) is primarily associated with an intensified inflammatory response within macrophage inflammasomes. This increased activity initiates pyroptotic cell death in macrophages, a process meticulously regulated by the protein gasdermin D (GSDMD). The precise role of macrophage pyroptosis in NEC is yet to be comprehensively understood. Our research explores the critical role of GSDMD in macrophage pyroptosis during experimental NEC. We have discovered a significant correlation between GSDMD and macrophage pyroptosis in the terminal ileum of infants afflicted with NEC. By utilizing GSDMD-deficient models and disulfiram, a compound that disrupts GSDMD-mediated pore formation, we observed a significant alleviation of NEC symptoms in mouse pups, along with a reduced presence of intestinal macrophages. Furthermore, bone marrow-derived macrophages (BMDMs) from GSDMD-deficient mice showed a decrease in overall macrophage numbers and a shift away from M1 polarization. Interestingly, although GSDMD inhibition bolstered the antibacterial capabilities of macrophages, their phagocytic activity towards zymosan particles remained unchanged. In summary, our findings underscore the essential function of GSDMD in regulating macrophage inflammasome responses and suggest that GSDMD could serve as a potential therapeutic target for NEC.
Indexed as
Identifiers
40824485What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.